Literature DB >> 12586530

Home diagnosis of the obstructive sleep apnoea/hypopnoea syndrome.

Neil J Douglas1.   

Abstract

Polysomnography has been accepted by many as a "gold standard" for the diagnosis of the Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS). Although polysomnography is a good method for diagnosing OSAHS, there is no evidence that the results of polysomnography more accurately identify patients with the syndrome than more simple investigations which may be done at lower cost in the patient's home. This article examines the evidence for and against home sleep studies and concludes that home sleep studies have a role. Precisely what that role is will depend on financial and organisational aspects for each sleep centre.

Entities:  

Mesh:

Year:  2003        PMID: 12586530     DOI: 10.1053/smrv.2001.0205

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  5 in total

1.  Home sleep testing for obstructive sleep apnea: one night is enough!

Authors:  Naresh M Punjabi; R Nisha Aurora; Susheel P Patil
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

2.  Sleepiness and sleep-disordered breathing during pregnancy.

Authors:  Maria Sarberg; Marie Bladh; Ann Josefsson; Eva Svanborg
Journal:  Sleep Breath       Date:  2016-04-16       Impact factor: 2.816

3.  An automated sleep-analysis system operated through a standard hospital monitor.

Authors:  Offer Amir; Deganit Barak-Shinar; Yariv Amos; Mary MacDonald; Stephen Pittman; David P White
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

4.  Oximetry alone versus portable polygraphy for sleep apnea screening before bariatric surgery.

Authors:  Maude Malbois; Vittorio Giusti; Michel Suter; Cyril Pellaton; Jean-Frédéric Vodoz; Raphael Heinzer
Journal:  Obes Surg       Date:  2010-01-06       Impact factor: 4.129

5.  Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study.

Authors:  Jan Magnus Fredheim; Jan Rollheim; Torbjørn Omland; Dag Hofsø; Jo Røislien; Kristian Vegsgaard; Jøran Hjelmesæth
Journal:  Cardiovasc Diabetol       Date:  2011-09-25       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.